[177Lu]lu-Psma-617 Plus Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer (Enza-P): an Open-Label, Multicentre, Randomised, Phase 2 Trial Louise Emmett , Shalini Subramaniam , Megan Crumbaker , Andrew Nguyen , Anthony M. Joshua , Andrew Weickhardt , Sze-Ting Lee , Siobhan Ng , Roslyn J. Francis , Jeffrey C. Goh , David A. Pattison , Thean Hsiang Tan , Ian D. Kirkwood , Craig Gedye , Natalie K. Rutherford , Shahneen Sandhu , Aravind Ravi Kumar , David Pook , Shakher Ramdave , David P. Nadebaum , Mark Voskoboynik , Andrew D. Redfern , William Macdonald , Laurence Krieger , Geoff Schembri , Wei Chua , Peter Lin , Lisa Horvath , Patricia Bastick , Patrick Butler , Alison Yan Zhang , Sonia Yip , Hayley Thomas , Ailsa Langford , Michael S. Hofman , Margaret Mcjannett , Andrew James Martin , Martin R. Stockler , Ian D. Davis LANCET ONCOLOGY（2024）
Key words
Metastatic Prostate Cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
